Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
about
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceSpines, plasticity, and cognition in Alzheimer's model miceVitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic miceAltered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.Microglia change from a reactive to an age-like phenotype with the time in cultureFluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice.APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI studyAge-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus.Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice.Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks.Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning.In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy.Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer's diseaseA novel approach to rapidly prevent age-related cognitive declineSystematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease.Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer's drug candidatesThe impact of glial activation in the aging brainPreferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease.Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models.Mesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer's Disease.Chronic Pyruvate Supplementation Increases Exploratory Activity and Brain Energy Reserves in Young and Middle-Aged Mice.BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease.The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease.Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.Preservation of Cognitive Function by Lepidium meyenii (Maca) Is Associated with Improvement of Mitochondrial Activity and Upregulation of Autophagy-Related Proteins in Middle-Aged Mouse CortexImprovement of Electroacupuncture on APP/PS1 Transgenic Mice in Spatial Learning and Memory Probably due to Expression of Aβ and LRP1 in Hippocampus.Susceptibility to focal and global brain ischemia of Alzheimer mice displaying aβ deposits: effect of immunoglobulinAge-related brain expression and regulation of the chemokine CCL4/MIP-1β in APP/PS1 double-transgenic mice.Utilization of APPswe/PS1dE9 Transgenic Mice in Research of Alzheimer's Disease: Focus on Gene Therapy and Cell-Based Therapy Applications.Wading pools, fading memories-place navigation in transgenic mouse models of Alzheimer's disease.Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine.Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice.Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1.Low-dose proton radiation effects in a transgenic mouse model of Alzheimer's disease - Implications for space travel.Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β.Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AβPP/PS1 Mice.
P2860
Q21195685-8384A431-BBCD-4567-983A-1B6E01515060Q27691328-ABDFEBE9-F8F7-4375-9201-45B6496B6B72Q28534524-2C562DAD-BB70-4AD7-BCE2-635A72E963A0Q30640315-A33EE028-5CE8-4869-8AC6-0F4AB0932866Q33695687-72CB73E1-5F5E-4100-A01E-30C02113BA44Q33709399-424D962B-3292-4F5D-BA9B-BE3F5279D974Q33812308-5F7E6014-ED54-43B3-85AE-49305779ADC9Q34080432-B3A6CADF-20BB-4B08-84C0-B52D2F41FB55Q34238362-4DB3A7EA-E8A7-4FC1-A5E0-CC60030D6162Q34524924-4F86434C-BB3F-411A-9C25-E7C596382568Q34609558-7E526F90-F295-47AA-B94F-C6DC1DE21331Q35002449-36EA644D-BEA5-4685-9613-FD7D39D706FBQ35014827-05FC83D6-092A-433C-81CB-A2717B891063Q35093133-1BFA521B-55E3-4C30-A1AC-1E96D7661304Q35137134-BC34DA7C-3BD1-463B-9962-4D3218E04945Q35167977-C015F0A8-CA4E-4560-92C1-30104579FCFFQ35806715-29043ACE-95B1-4A12-8919-29AC9FA7FC42Q35919768-82FE4284-76E6-41E0-83C2-CBC755251258Q36078803-2312F7B6-0987-4EC4-BEE3-BB11F965E97CQ36431280-E5FCD366-48C0-4EDD-8B2E-D256D2379122Q36536417-F5CFCF2A-0AE7-41DA-8CBD-E6FD241AD006Q36666929-932D048E-CC93-45E4-A1EB-09AB6A767C03Q36693936-EB31C7EE-811D-479A-816F-42DDFA115ADCQ36790844-A44CBDB2-DE41-4E05-8088-5AA2F93DF7ECQ36980971-78F4A9B8-AF42-4E5E-80C9-327AD8E48416Q37081974-5B519E26-013E-43B0-927B-096EBEE548F7Q37246557-326B64ED-DE67-440C-B0E3-AD84FED2699AQ37382608-F57A4B68-7946-4C09-9D3D-69DC81F95AA9Q37665371-44DE0F89-A029-4699-A9DC-490CCCEFF7A0Q37687400-231042A5-03EF-46E9-8FC4-408FDB76C457Q37960498-B87D2D7C-3AAA-4978-813C-36E8949A08A1Q38016418-9FFD6346-EB48-4021-B3D4-E3EC0D0127CEQ41444056-CF1D8861-FCBF-4D31-9804-661B0BD1AA9BQ42073963-6FF0B1F5-15F1-4EC6-A15C-777FBE080B66Q42474130-612B23A4-98B2-40BB-AC01-5B0CDA6312A1Q42513498-94F8BEA3-D552-4835-9548-760C121E70F7Q44467690-5C5FBEEF-6C1C-41F5-9028-13B5DC5D2DCFQ46158936-C98C2C97-85BB-4DB0-AC5E-B2818F2C4298Q46488630-6CA583C9-607C-4C63-91C1-064A340EAA4CQ47595528-2946AE71-6AB9-49B0-86D5-6E926AA4FF49
P2860
Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Age-related decrease in stimul ...... transgenic and wild-type mice.
@en
Age-related decrease in stimul ...... transgenic and wild-type mice.
@nl
type
label
Age-related decrease in stimul ...... transgenic and wild-type mice.
@en
Age-related decrease in stimul ...... transgenic and wild-type mice.
@nl
prefLabel
Age-related decrease in stimul ...... transgenic and wild-type mice.
@en
Age-related decrease in stimul ...... transgenic and wild-type mice.
@nl
P2093
P2860
P1476
Age-related decrease in stimul ...... transgenic and wild-type mice.
@en
P2093
Banerjee P
Goldsteins G
Ihalainen J
Keksa-Goldsteine V
Koistinaho J
Matilainen O
P2860
P304
P356
10.1111/J.1471-4159.2007.05147.X
P407
P577
2007-11-26T00:00:00Z